<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />

<meta name="author" content="Andrew J. Sims" />


<title>Markov Model with transition costs (Willits 2012)</title>

<script src="data:application/javascript;base64,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"></script>

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>


<style type="text/css">
  code {
    white-space: pre;
  }
  .sourceCode {
    overflow: visible;
  }
</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
  { counter-reset: source-line 0; }
pre.numberSource code > span
  { position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
  { content: counter(source-line);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {   }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */

</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<style type="text/css">
/* for pandoc --citeproc since 2.11 */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="data:text/css,body%20%7B%0Abackground%2Dcolor%3A%20%23fff%3B%0Amargin%3A%201em%20auto%3B%0Amax%2Dwidth%3A%20700px%3B%0Aoverflow%3A%20visible%3B%0Apadding%2Dleft%3A%202em%3B%0Apadding%2Dright%3A%202em%3B%0Afont%2Dfamily%3A%20%22Open%20Sans%22%2C%20%22Helvetica%20Neue%22%2C%20Helvetica%2C%20Arial%2C%20sans%2Dserif%3B%0Afont%2Dsize%3A%2014px%3B%0Aline%2Dheight%3A%201%2E35%3B%0A%7D%0A%23TOC%20%7B%0Aclear%3A%20both%3B%0Amargin%3A%200%200%2010px%2010px%3B%0Apadding%3A%204px%3B%0Awidth%3A%20400px%3B%0Aborder%3A%201px%20solid%20%23CCCCCC%3B%0Aborder%2Dradius%3A%205px%3B%0Abackground%2Dcolor%3A%20%23f6f6f6%3B%0Afont%2Dsize%3A%2013px%3B%0Aline%2Dheight%3A%201%2E3%3B%0A%7D%0A%23TOC%20%2Etoctitle%20%7B%0Afont%2Dweight%3A%20bold%3B%0Afont%2Dsize%3A%2015px%3B%0Amargin%2Dleft%3A%205px%3B%0A%7D%0A%23TOC%20ul%20%7B%0Apadding%2Dleft%3A%2040px%3B%0Amargin%2Dleft%3A%20%2D1%2E5em%3B%0Amargin%2Dtop%3A%205px%3B%0Amargin%2Dbottom%3A%205px%3B%0A%7D%0A%23TOC%20ul%20ul%20%7B%0Amargin%2Dleft%3A%20%2D2em%3B%0A%7D%0A%23TOC%20li%20%7B%0Aline%2Dheight%3A%2016px%3B%0A%7D%0Atable%20%7B%0Amargin%3A%201em%20auto%3B%0Aborder%2Dwidth%3A%201px%3B%0Aborder%2Dcolor%3A%20%23DDDDDD%3B%0Aborder%2Dstyle%3A%20outset%3B%0Aborder%2Dcollapse%3A%20collapse%3B%0A%7D%0Atable%20th%20%7B%0Aborder%2Dwidth%3A%202px%3B%0Apadding%3A%205px%3B%0Aborder%2Dstyle%3A%20inset%3B%0A%7D%0Atable%20td%20%7B%0Aborder%2Dwidth%3A%201px%3B%0Aborder%2Dstyle%3A%20inset%3B%0Aline%2Dheight%3A%2018px%3B%0Apadding%3A%205px%205px%3B%0A%7D%0Atable%2C%20table%20th%2C%20table%20td%20%7B%0Aborder%2Dleft%2Dstyle%3A%20none%3B%0Aborder%2Dright%2Dstyle%3A%20none%3B%0A%7D%0Atable%20thead%2C%20table%20tr%2Eeven%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0A%7D%0Ap%20%7B%0Amargin%3A%200%2E5em%200%3B%0A%7D%0Ablockquote%20%7B%0Abackground%2Dcolor%3A%20%23f6f6f6%3B%0Apadding%3A%200%2E25em%200%2E75em%3B%0A%7D%0Ahr%20%7B%0Aborder%2Dstyle%3A%20solid%3B%0Aborder%3A%20none%3B%0Aborder%2Dtop%3A%201px%20solid%20%23777%3B%0Amargin%3A%2028px%200%3B%0A%7D%0Adl%20%7B%0Amargin%2Dleft%3A%200%3B%0A%7D%0Adl%20dd%20%7B%0Amargin%2Dbottom%3A%2013px%3B%0Amargin%2Dleft%3A%2013px%3B%0A%7D%0Adl%20dt%20%7B%0Afont%2Dweight%3A%20bold%3B%0A%7D%0Aul%20%7B%0Amargin%2Dtop%3A%200%3B%0A%7D%0Aul%20li%20%7B%0Alist%2Dstyle%3A%20circle%20outside%3B%0A%7D%0Aul%20ul%20%7B%0Amargin%2Dbottom%3A%200%3B%0A%7D%0Apre%2C%20code%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0Aborder%2Dradius%3A%203px%3B%0Acolor%3A%20%23333%3B%0Awhite%2Dspace%3A%20pre%2Dwrap%3B%20%0A%7D%0Apre%20%7B%0Aborder%2Dradius%3A%203px%3B%0Amargin%3A%205px%200px%2010px%200px%3B%0Apadding%3A%2010px%3B%0A%7D%0Apre%3Anot%28%5Bclass%5D%29%20%7B%0Abackground%2Dcolor%3A%20%23f7f7f7%3B%0A%7D%0Acode%20%7B%0Afont%2Dfamily%3A%20Consolas%2C%20Monaco%2C%20%27Courier%20New%27%2C%20monospace%3B%0Afont%2Dsize%3A%2085%25%3B%0A%7D%0Ap%20%3E%20code%2C%20li%20%3E%20code%20%7B%0Apadding%3A%202px%200px%3B%0A%7D%0Adiv%2Efigure%20%7B%0Atext%2Dalign%3A%20center%3B%0A%7D%0Aimg%20%7B%0Abackground%2Dcolor%3A%20%23FFFFFF%3B%0Apadding%3A%202px%3B%0Aborder%3A%201px%20solid%20%23DDDDDD%3B%0Aborder%2Dradius%3A%203px%3B%0Aborder%3A%201px%20solid%20%23CCCCCC%3B%0Amargin%3A%200%205px%3B%0A%7D%0Ah1%20%7B%0Amargin%2Dtop%3A%200%3B%0Afont%2Dsize%3A%2035px%3B%0Aline%2Dheight%3A%2040px%3B%0A%7D%0Ah2%20%7B%0Aborder%2Dbottom%3A%204px%20solid%20%23f7f7f7%3B%0Apadding%2Dtop%3A%2010px%3B%0Apadding%2Dbottom%3A%202px%3B%0Afont%2Dsize%3A%20145%25%3B%0A%7D%0Ah3%20%7B%0Aborder%2Dbottom%3A%202px%20solid%20%23f7f7f7%3B%0Apadding%2Dtop%3A%2010px%3B%0Afont%2Dsize%3A%20120%25%3B%0A%7D%0Ah4%20%7B%0Aborder%2Dbottom%3A%201px%20solid%20%23f7f7f7%3B%0Amargin%2Dleft%3A%208px%3B%0Afont%2Dsize%3A%20105%25%3B%0A%7D%0Ah5%2C%20h6%20%7B%0Aborder%2Dbottom%3A%201px%20solid%20%23ccc%3B%0Afont%2Dsize%3A%20105%25%3B%0A%7D%0Aa%20%7B%0Acolor%3A%20%230033dd%3B%0Atext%2Ddecoration%3A%20none%3B%0A%7D%0Aa%3Ahover%20%7B%0Acolor%3A%20%236666ff%3B%20%7D%0Aa%3Avisited%20%7B%0Acolor%3A%20%23800080%3B%20%7D%0Aa%3Avisited%3Ahover%20%7B%0Acolor%3A%20%23BB00BB%3B%20%7D%0Aa%5Bhref%5E%3D%22http%3A%22%5D%20%7B%0Atext%2Ddecoration%3A%20underline%3B%20%7D%0Aa%5Bhref%5E%3D%22https%3A%22%5D%20%7B%0Atext%2Ddecoration%3A%20underline%3B%20%7D%0A%0Acode%20%3E%20span%2Ekw%20%7B%20color%3A%20%23555%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%0Acode%20%3E%20span%2Edt%20%7B%20color%3A%20%23902000%3B%20%7D%20%0Acode%20%3E%20span%2Edv%20%7B%20color%3A%20%2340a070%3B%20%7D%20%0Acode%20%3E%20span%2Ebn%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Efl%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Ech%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Est%20%7B%20color%3A%20%23d14%3B%20%7D%20%0Acode%20%3E%20span%2Eco%20%7B%20color%3A%20%23888888%3B%20font%2Dstyle%3A%20italic%3B%20%7D%20%0Acode%20%3E%20span%2Eot%20%7B%20color%3A%20%23007020%3B%20%7D%20%0Acode%20%3E%20span%2Eal%20%7B%20color%3A%20%23ff0000%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%0Acode%20%3E%20span%2Efu%20%7B%20color%3A%20%23900%3B%20font%2Dweight%3A%20bold%3B%20%7D%20%0Acode%20%3E%20span%2Eer%20%7B%20color%3A%20%23a61717%3B%20background%2Dcolor%3A%20%23e3d2d2%3B%20%7D%20%0A" type="text/css" />




</head>

<body>




<h1 class="title toc-ignore">Markov Model with transition costs (Willits 2012)</h1>
<h3 class="subtitle">Cost impact of the WatchBP Home A used in primary healthcare</h3>
<h4 class="author">Andrew J. Sims</h4>
<h4 class="date">May 2021</h4>



<div id="introduction" class="section level1">
<h1>Introduction</h1>
<p>This vignette describes a Markov model that was used to evaluate the cost consequences of opportunistic screening for atrial fibrillation (AF) during clinic visits involving blood pressure measurement. It was first developed for the assessment of the WatchBP oscillometric blood pressure measurement device by the National Institute of Health and Care Excellence (NICE)<span class="citation"><sup>1</sup></span> and is described fully in a report that was published during the guidance development process.<span class="citation"><sup>2</sup></span></p>
<p>The guidance report followed two cohorts, those aged 65-74 and those aged 75-84, to account for the age dependency in risk of AF. This vignette focuses on the older cohort.</p>
</div>
<div id="diagnostic-phase" class="section level1">
<h1>Diagnostic phase</h1>
<p>The diagnostic phase was modelled as a decision tree in which the diagnostic test accuracies of the index technology (WatchBP) and the comparator technology (pulse palpation) were used to estimate the proportions of the cohort falling into the true positive (TP), true negative (TN), false positive (FP) and false negative (FN) categories. These proportions were used to define the starting populations in the management phase (a Markov model) with a cohort size of 10^{5}. In the diagnostic phase the prevalance of AF was 0.072; WatchBP had a sensitivity of 0.967 and a specificity of 0.888; pulse palpation had a sensitivity of 0.872 and a specificity of 0.813.</p>
<p>The number of patients predicted to be in each of the four categories for each test is shown in the table below.</p>
<table style="width:42%;">
<colgroup>
<col width="9%" />
<col width="13%" />
<col width="18%" />
</colgroup>
<thead>
<tr class="header">
<th align="center">Leaf</th>
<th align="center">Test</th>
<th align="center">Population</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="center">TP</td>
<td align="center">WatchBP</td>
<td align="center">6962</td>
</tr>
<tr class="even">
<td align="center">FP</td>
<td align="center">WatchBP</td>
<td align="center">10394</td>
</tr>
<tr class="odd">
<td align="center">FN</td>
<td align="center">WatchBP</td>
<td align="center">237.6</td>
</tr>
<tr class="even">
<td align="center">TN</td>
<td align="center">WatchBP</td>
<td align="center">82406</td>
</tr>
<tr class="odd">
<td align="center">TP</td>
<td align="center">PP</td>
<td align="center">6278</td>
</tr>
<tr class="even">
<td align="center">FP</td>
<td align="center">PP</td>
<td align="center">17354</td>
</tr>
<tr class="odd">
<td align="center">FN</td>
<td align="center">PP</td>
<td align="center">921.6</td>
</tr>
<tr class="even">
<td align="center">TN</td>
<td align="center">PP</td>
<td align="center">75446</td>
</tr>
</tbody>
</table>
</div>
<div id="management-phase" class="section level1">
<h1>Management phase</h1>
<div id="model-variables" class="section level2">
<h2>Model variables</h2>
<p>The model variables used in the management phase are as follows:</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" aria-hidden="true" tabindex="-1"></a><span class="co"># risks of GI bleed for each therapy (per year)</span></span>
<span id="cb1-2"><a href="#cb1-2" aria-hidden="true" tabindex="-1"></a>r.GB.ap <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="fl">-0.016</span>)<span class="sc">/</span><span class="dv">1</span></span>
<span id="cb1-3"><a href="#cb1-3" aria-hidden="true" tabindex="-1"></a>r.GB.ac <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="fl">-0.014</span>)<span class="sc">/</span><span class="dv">1</span></span>
<span id="cb1-4"><a href="#cb1-4" aria-hidden="true" tabindex="-1"></a><span class="co"># SMR for a person aged 79</span></span>
<span id="cb1-5"><a href="#cb1-5" aria-hidden="true" tabindex="-1"></a>r.SMR <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="fl">-0.0593</span>)<span class="sc">/</span><span class="dv">1</span></span>
<span id="cb1-6"><a href="#cb1-6" aria-hidden="true" tabindex="-1"></a><span class="co"># CHADS2 annual risk of stroke</span></span>
<span id="cb1-7"><a href="#cb1-7" aria-hidden="true" tabindex="-1"></a>p.CHADS2<span class="fl">.1</span> <span class="ot">&lt;-</span> <span class="fl">0.028</span></span>
<span id="cb1-8"><a href="#cb1-8" aria-hidden="true" tabindex="-1"></a>p.CHADS2<span class="fl">.2</span> <span class="ot">&lt;-</span> <span class="fl">0.040</span></span>
<span id="cb1-9"><a href="#cb1-9" aria-hidden="true" tabindex="-1"></a>p.CHADS2<span class="fl">.3</span> <span class="ot">&lt;-</span> <span class="fl">0.059</span></span>
<span id="cb1-10"><a href="#cb1-10" aria-hidden="true" tabindex="-1"></a>p.CHADS2<span class="fl">.4</span> <span class="ot">&lt;-</span> <span class="fl">0.085</span></span>
<span id="cb1-11"><a href="#cb1-11" aria-hidden="true" tabindex="-1"></a>p.CHADS2<span class="fl">.5</span> <span class="ot">&lt;-</span> <span class="fl">0.125</span></span>
<span id="cb1-12"><a href="#cb1-12" aria-hidden="true" tabindex="-1"></a>p.CHADS2<span class="fl">.6</span> <span class="ot">&lt;-</span> <span class="fl">0.182</span></span>
<span id="cb1-13"><a href="#cb1-13" aria-hidden="true" tabindex="-1"></a><span class="co"># relative risk of stroke given therapy</span></span>
<span id="cb1-14"><a href="#cb1-14" aria-hidden="true" tabindex="-1"></a>rr.ap <span class="ot">&lt;-</span> <span class="fl">0.78</span></span>
<span id="cb1-15"><a href="#cb1-15" aria-hidden="true" tabindex="-1"></a>rr.ac <span class="ot">&lt;-</span> <span class="fl">0.32</span></span>
<span id="cb1-16"><a href="#cb1-16" aria-hidden="true" tabindex="-1"></a><span class="co"># risks of stroke (per year)</span></span>
<span id="cb1-17"><a href="#cb1-17" aria-hidden="true" tabindex="-1"></a>r.S1.ap <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="sc">-</span>p.CHADS2<span class="fl">.1</span><span class="sc">*</span>rr.ap)<span class="sc">/</span><span class="dv">1</span></span>
<span id="cb1-18"><a href="#cb1-18" aria-hidden="true" tabindex="-1"></a>r.S1.ac <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="sc">-</span>p.CHADS2<span class="fl">.1</span><span class="sc">*</span>rr.ac)<span class="sc">/</span><span class="dv">1</span></span>
<span id="cb1-19"><a href="#cb1-19" aria-hidden="true" tabindex="-1"></a>r.S2.ac <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="sc">-</span>p.CHADS2<span class="fl">.2</span><span class="sc">*</span>rr.ac)<span class="sc">/</span><span class="dv">1</span></span>
<span id="cb1-20"><a href="#cb1-20" aria-hidden="true" tabindex="-1"></a>r.S3.ac <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="sc">-</span>p.CHADS2<span class="fl">.3</span><span class="sc">*</span>rr.ac)<span class="sc">/</span><span class="dv">1</span></span>
<span id="cb1-21"><a href="#cb1-21" aria-hidden="true" tabindex="-1"></a>r.S4.ac <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="sc">-</span>p.CHADS2<span class="fl">.4</span><span class="sc">*</span>rr.ac)<span class="sc">/</span><span class="dv">1</span></span>
<span id="cb1-22"><a href="#cb1-22" aria-hidden="true" tabindex="-1"></a>r.S5.ac <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="sc">-</span>p.CHADS2<span class="fl">.5</span><span class="sc">*</span>rr.ac)<span class="sc">/</span><span class="dv">1</span></span>
<span id="cb1-23"><a href="#cb1-23" aria-hidden="true" tabindex="-1"></a>r.S6.ac <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="sc">-</span>p.CHADS2<span class="fl">.6</span><span class="sc">*</span>rr.ac)<span class="sc">/</span><span class="dv">1</span></span>
<span id="cb1-24"><a href="#cb1-24" aria-hidden="true" tabindex="-1"></a><span class="co"># risks of fatal stroke in year 1 and in subsequent years</span></span>
<span id="cb1-25"><a href="#cb1-25" aria-hidden="true" tabindex="-1"></a>r.SF<span class="fl">.1</span> <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="fl">-0.333</span>)<span class="sc">/</span><span class="dv">1</span></span>
<span id="cb1-26"><a href="#cb1-26" aria-hidden="true" tabindex="-1"></a>r.SF.N <span class="ot">&lt;-</span> <span class="sc">-</span><span class="fu">log</span>(<span class="dv">1</span><span class="fl">-0.100</span>)<span class="sc">/</span><span class="dv">1</span></span></code></pre></div>
</div>
<div id="model-structure" class="section level2">
<h2>Model structure</h2>
<p>A Markov model was constructed with six states (Fig 1): AF, GI bleed, stroke (year 1), stroke (subsequent years), fatal stroke and dead. The GI bleed state was a tunnel state, which patients occupied for 1 cycle before returning to the AF state. The fatal stroke and dead states were absorbing states. The stroke in year 1 had no self loop and thus a maximum occupancy of 1 cycle.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" aria-hidden="true" tabindex="-1"></a><span class="co"># AF state</span></span>
<span id="cb2-2"><a href="#cb2-2" aria-hidden="true" tabindex="-1"></a>AF <span class="ot">&lt;-</span> MarkovState<span class="sc">$</span><span class="fu">new</span>(<span class="st">&quot;AF&quot;</span>)</span>
<span id="cb2-3"><a href="#cb2-3" aria-hidden="true" tabindex="-1"></a><span class="co"># disease states</span></span>
<span id="cb2-4"><a href="#cb2-4" aria-hidden="true" tabindex="-1"></a>GB <span class="ot">&lt;-</span> MarkovState<span class="sc">$</span><span class="fu">new</span>(<span class="st">&quot;GIbleed&quot;</span>)</span>
<span id="cb2-5"><a href="#cb2-5" aria-hidden="true" tabindex="-1"></a>S1 <span class="ot">&lt;-</span> MarkovState<span class="sc">$</span><span class="fu">new</span>(<span class="st">&quot;StrokeY1&quot;</span>)</span>
<span id="cb2-6"><a href="#cb2-6" aria-hidden="true" tabindex="-1"></a>SN <span class="ot">&lt;-</span> MarkovState<span class="sc">$</span><span class="fu">new</span>(<span class="st">&quot;StrokeYN&quot;</span>)</span>
<span id="cb2-7"><a href="#cb2-7" aria-hidden="true" tabindex="-1"></a>SF <span class="ot">&lt;-</span> MarkovState<span class="sc">$</span><span class="fu">new</span>(<span class="st">&quot;FatalStroke&quot;</span>)</span>
<span id="cb2-8"><a href="#cb2-8" aria-hidden="true" tabindex="-1"></a>D <span class="ot">&lt;-</span> MarkovState<span class="sc">$</span><span class="fu">new</span>(<span class="st">&quot;Dead&quot;</span>)</span>
<span id="cb2-9"><a href="#cb2-9" aria-hidden="true" tabindex="-1"></a><span class="co"># transitions</span></span>
<span id="cb2-10"><a href="#cb2-10" aria-hidden="true" tabindex="-1"></a>E <span class="ot">&lt;-</span> <span class="fu">list</span>(</span>
<span id="cb2-11"><a href="#cb2-11" aria-hidden="true" tabindex="-1"></a>  <span class="co"># from AF</span></span>
<span id="cb2-12"><a href="#cb2-12" aria-hidden="true" tabindex="-1"></a>  MarkovTransition<span class="sc">$</span><span class="fu">new</span>(AF, AF, <span class="at">r=</span><span class="cn">NULL</span>),</span>
<span id="cb2-13"><a href="#cb2-13" aria-hidden="true" tabindex="-1"></a>  MarkovTransition<span class="sc">$</span><span class="fu">new</span>(AF, GB, <span class="at">r=</span>r.GB.ap),</span>
<span id="cb2-14"><a href="#cb2-14" aria-hidden="true" tabindex="-1"></a>  MarkovTransition<span class="sc">$</span><span class="fu">new</span>(AF, D, <span class="at">r=</span>r.SMR),</span>
<span id="cb2-15"><a href="#cb2-15" aria-hidden="true" tabindex="-1"></a>  MarkovTransition<span class="sc">$</span><span class="fu">new</span>(AF, S1, <span class="at">r=</span>r.S1.ap),</span>
<span id="cb2-16"><a href="#cb2-16" aria-hidden="true" tabindex="-1"></a>  <span class="co"># from GI bleed</span></span>
<span id="cb2-17"><a href="#cb2-17" aria-hidden="true" tabindex="-1"></a>  MarkovTransition<span class="sc">$</span><span class="fu">new</span>(GB, AF, <span class="at">r=</span><span class="cn">NULL</span>),</span>
<span id="cb2-18"><a href="#cb2-18" aria-hidden="true" tabindex="-1"></a>  <span class="co"># from stroke, year 1</span></span>
<span id="cb2-19"><a href="#cb2-19" aria-hidden="true" tabindex="-1"></a>  MarkovTransition<span class="sc">$</span><span class="fu">new</span>(S1, SF, <span class="at">r=</span>r.SF<span class="fl">.1</span>),</span>
<span id="cb2-20"><a href="#cb2-20" aria-hidden="true" tabindex="-1"></a>  MarkovTransition<span class="sc">$</span><span class="fu">new</span>(S1, SN, <span class="at">r=</span><span class="cn">NULL</span>),</span>
<span id="cb2-21"><a href="#cb2-21" aria-hidden="true" tabindex="-1"></a>  <span class="co"># from stroke, subsequent years</span></span>
<span id="cb2-22"><a href="#cb2-22" aria-hidden="true" tabindex="-1"></a>  MarkovTransition<span class="sc">$</span><span class="fu">new</span>(SN, SN, <span class="at">r=</span><span class="cn">NULL</span>),</span>
<span id="cb2-23"><a href="#cb2-23" aria-hidden="true" tabindex="-1"></a>  MarkovTransition<span class="sc">$</span><span class="fu">new</span>(SN, SF, <span class="at">r=</span>r.SF.N),</span>
<span id="cb2-24"><a href="#cb2-24" aria-hidden="true" tabindex="-1"></a>  <span class="co"># abosrbing states</span></span>
<span id="cb2-25"><a href="#cb2-25" aria-hidden="true" tabindex="-1"></a>  MarkovTransition<span class="sc">$</span><span class="fu">new</span>(D, D),</span>
<span id="cb2-26"><a href="#cb2-26" aria-hidden="true" tabindex="-1"></a>  MarkovTransition<span class="sc">$</span><span class="fu">new</span>(SF, SF)</span>
<span id="cb2-27"><a href="#cb2-27" aria-hidden="true" tabindex="-1"></a>)</span>
<span id="cb2-28"><a href="#cb2-28" aria-hidden="true" tabindex="-1"></a><span class="co"># create model</span></span>
<span id="cb2-29"><a href="#cb2-29" aria-hidden="true" tabindex="-1"></a>CM <span class="ot">&lt;-</span> CohortMarkovModel<span class="sc">$</span><span class="fu">new</span>(</span>
<span id="cb2-30"><a href="#cb2-30" aria-hidden="true" tabindex="-1"></a>  <span class="at">V =</span> <span class="fu">list</span>(AF, GB, D, S1, SN, SF),</span>
<span id="cb2-31"><a href="#cb2-31" aria-hidden="true" tabindex="-1"></a>  E </span>
<span id="cb2-32"><a href="#cb2-32" aria-hidden="true" tabindex="-1"></a>)</span></code></pre></div>
<p>The per-cycle transition probability matrix for one scenario (patients with AF, CHADS2 score of 1 and antiplatelet therapy) is shown below.</p>
<table>
<colgroup>
<col width="17%" />
<col width="11%" />
<col width="12%" />
<col width="11%" />
<col width="14%" />
<col width="14%" />
<col width="17%" />
</colgroup>
<thead>
<tr class="header">
<th align="left"> </th>
<th align="center">AF</th>
<th align="center">GIbleed</th>
<th align="center">Dead</th>
<th align="center">StrokeY1</th>
<th align="center">StrokeYN</th>
<th align="center">FatalStroke</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">AF</td>
<td align="center">0.9029</td>
<td align="center">0.016</td>
<td align="center">0.0593</td>
<td align="center">0.02184</td>
<td align="center">0</td>
<td align="center">0</td>
</tr>
<tr class="even">
<td align="left">GIbleed</td>
<td align="center">1</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
</tr>
<tr class="odd">
<td align="left">Dead</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">1</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
</tr>
<tr class="even">
<td align="left">StrokeY1</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0.667</td>
<td align="center">0.333</td>
</tr>
<tr class="odd">
<td align="left">StrokeYN</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0.9</td>
<td align="center">0.1</td>
</tr>
<tr class="even">
<td align="left">FatalStroke</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">1</td>
</tr>
</tbody>
</table>
</div>
</div>
<div id="references" class="section level1 unnumbered">
<h1 class="unnumbered">References</h1>
<div id="refs" class="references csl-bib-body">
<div id="ref-willits2014a" class="csl-entry">
<div class="csl-left-margin">1 </div><div class="csl-right-inline">Willits I, Keltie K, Craig J, Sims A. <span>WatchBP Home A</span> for <span>Opportunistically Detecting Atrial Fibrillation During Diagnosis</span> and <span>Monitoring</span> of <span>Hypertension</span>: <span>A NICE Medical Technology Guidance</span>. <em>Applied Health Economics and Health Policy</em> 2014;<strong>12</strong>:255–65. <a href="https://doi.org/10.1007/s40258-014-0096-7">https://doi.org/10.1007/s40258-014-0096-7</a>.</div>
</div>
<div id="ref-willits2012a" class="csl-entry">
<div class="csl-left-margin">2 </div><div class="csl-right-inline">Willits I, Keltie K, Craig J, Sims AJ. <em>Cost impact of the <span>WatchBP Home A</span> used in a primary healthcare clinic environment</em>. <span>National Institute for Health and Care Excellence</span>; 2012.</div>
</div>
</div>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
